Clinician and Patient Evaluation of Improvement for Eyebrow and Eyelashes Hair Loss During Baricitinib Phase 3 Trials BRAVE-AA1 and BRAVE-AA2

    September 2022 in “ Journal of The American Academy of Dermatology ”
    Brett King, Manabu Ohyama, Arash Mostaghimi
    Studysummary This study found that baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata, with similar improvements observed in both clinician-reported and patient-reported measures.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Related research 5

    1. Baricitinib Results in Eyebrow and Eyelash Growth in Patients With Alopecia Areata Who Do Not Achieve 20% or Less Scalp Hair Loss Journal of The American Academy of Dermatology · 2022
    2. Acitretin-Induced Alopecia Areata: A Case Report Cutaneous and ocular toxicology · 2014
    3. Alopecia Areata of Eyelashes: Regrowth After Injecting Triamcinolone Into the Eyebrow Area Journal of the American Academy of Dermatology · 2009
    4. Lack of Efficacy of Topical Latanoprost in the Treatment of Eyebrow Alopecia Areata Journal of The American Academy of Dermatology · 2005
    5. Successful Hair Transplant of Eyebrow Alopecia Areata Journal of the American Academy of Dermatology · 2005